Novavax Inc (NVAX)

Overview News Price History Option Chain Financials Why NVAX Down? Discussions Forecast Stock Split

Novavax Inc Stock (NVAX) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	67.79% 93.86	291.34	186.99	424.43	80.95
Cost Of Revenue	61.79% 59.21	154.98	98.93	55.78	34.09
Gross Profit	74.59% 34.65	136.37	88.06	368.65	46.87
Operating Expenses	43.90% 179.48	319.93	213.69	313.19	359.63
Interest Income/Expense	0.15% 4.111	4.117	2.859	3.124	4.316
Benefits Costs and Expenses	48.91% 239.14	468.04	318.46	366.56	373.67
Costs And Expenses	49.74% 238.69	474.91	312.62	368.97	393.72
Depreciation and Amortization	12.53% 12.15	10.79	11.32	10.07	9.043
Operating Income/Loss	21.10% -144.83	-183.57	-125.63	55.46	-312.77
Income/Loss From Continuing Operations Before Tax	17.78% -145.29	-176.70	-131.47	57.87	-292.72
Income Tax Expense/Benefit	34.00% 2.262	1.688	-0.697	-0.143	1.183
Income/Loss From Continuing Operations After Tax	17.29% -147.55	-178.39	-130.78	58.01	-293.90
Net Income/Loss	17.29% -147.55	-178.39	-130.78	58.01	-293.90
Preferred Stock Dividends And Other Adjustments	285.19% 0.05	-0.027	-	-	-0.005
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,712% 139.92	7.722	103.43	89.36	86.16
Diluted Average Shares	1,712% 139.92	7.722	103.43	104.06	86.16
Basic Earnings Per Share	28.57% -1.05	-1.47	-1.26	0.65	-3.41
Diluted Earnings Per Share	28.57% -1.05	-1.47	-1.26	0.58	-3.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	285.19% 0.05	-0.027	-	-	-0.005

SMMT

$18.94

1.35%

INCY

$75.45

0.87%

MRNA

$43.39

3.19%

UTHR

$378.13

0.30%

BGNE

$206.16

7.31%

BNTX

$120.72

1.84%